Mahafzah Medical Center — Evergreen Park, Illinois

Mahafzah Medical Center is a clinical research site located in Evergreen Park, Illinois, United States 60805.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Mahafzah Medical Center has participated in 1 clinical trials.

Therapeutic areas: Chronic Myeloid Leukemia.

Sponsors: Bristol-Myers Squibb.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Evergreen Park

Browse all research sites in Illinois · View every site in Evergreen Park

• Little Company of Mary Hospital
• University of Chicago Medicine Comprehensive Cancer Center
• Little Company of Mary Hospital - Evergreen Park
• University of Chicago
• OSF Little Company of Mary Hospital
• Research by Design
• GSK Investigational Site
• Research Site
• Providea Health Partners
• Pharmakon Inc
• Fresenius Medical Care of Evergreen Park
• GenHarp Clinical Solutions

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mahafzah Medical Center?

Mahafzah Medical Center has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mahafzah Medical Center conducted?

Mahafzah Medical Center has 1 clinical trials on record. Their work covers Chronic Myeloid Leukemia.

Is Mahafzah Medical Center accredited by Crixeo Clinical Trials?

Mahafzah Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Mahafzah Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.